Background The SARS-CoV-2 virus is the causative agent of the emerging respiratory
zoonosis disease. One of the most important requirements for the control of emerging …

BACKGROUND: Mass vaccination against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is ongoing amidst widespread transmission during the Coronavirus Disease …

Background Mass vaccination against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is ongoing amidst widespread transmission during the coronavirus disease …

COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since
there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become …

The availability of a safe and effective vaccine would be the eventual measure to deal with
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) threat. Here, we have …

Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in
clinical development and 173 are in the pre-clinical phase. Five types of vaccines are …

The novel coronavirus (SARS-CoV-2) epidemic continues to be a global public crisis
affecting human health. Many research groups are developing different types of vaccines to …

Due to the rapid development of new variants of SARS-CoV-2 as well as the real threat of
new coronavirus zoonosis events, the development of a preventive vaccine with a broader …

In novel coronavirus infection (COVID-19), the outbreak of acute lung injury due to trans-
airway infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is …

The recent viral infection disease pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the …